Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 131 clinical trials
Featured trial
Inflammatory Characterization of Known or Possible Cardiovascular Diseases

PET/MRI). The procedures are similar to the FDG PET/CT scan. These other scans will last about 30 minutes total. Some participants will also have a CT scan of their heart. A substance will be

fats
diabetes
heart disease
  • 167 views
  • 23 Nov, 2020
  • 1 location
Comparison of the Short-Term Effect of Dietary Carbohydrate Restriction Versus Exogenous Ketone Supplementation on Myocardial Glucose Suppression and Timing to Achieve a State of Ketosis Using FDG PET/CT Serial Imaging

The purpose of this study is to test different methods of preparation that can be used prior to a test called an FDG PET/CT scan. FDG PET/CT scans are routinely done for evaluation of heart

Accepts healthy volunteers
  • 50 views
  • 27 Feb, 2022
  • 1 location
Imaging of Tumour Microenvironment in Patients With Oropharyngeal Head and Neck Squamous Cell Carcinoma Using RGD PET/CT Imaging (PIVOT)

vascularity. Therefore the vasculature is imaged with the help of a study specific Gallium-68-DOTA-(RGD)2 PET/CT scan and a CT perfusion scan.

ct scan
human papillomavirus
squamous cell carcinoma of the head and neck
oropharyngeal carcinoma
chemoradiotherapy
  • 1 views
  • 23 Feb, 2022
  • 1 location
[18F]Fluorothymidine (FLT) PET/CT Imaging In Rb+ Metastatic Breast Cancer Patients Undergoing LEE011 And Weekly Paclitaxel Therapy

therapy on the separate therapeutic protocol UPCC 06115. Patients may undergo a second FLT PET/CT scan following a 3-day run of ribociclib (LEE011) (day -6 to -4) on Day -3 ( 1 day) and a third FLT PET/CT

advanced breast cancer
paclitaxel
HER2
erbb2
  • 15 views
  • 08 Nov, 2020
  • 1 location
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer

during a positron emission tomography/computed tomography (PET/CT) scan. This information might help guide future research and treatment. Objective To identify the

  • 5 views
  • 21 Jul, 2022
  • 1 location
Phase II Trial of 18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy

> Blood tests MRI Participants will have baseline MRI and PET/CT scans. For the MRI, they may get a contrast agent by IV injection. For the PET/CT scan, they will get an IV

  • 0 views
  • 21 Sep, 2022
  • 1 location
Imaging and Biopsy of HIV-Infected Individuals Undergoing Analytic Treatment Interruption

assigned to 1 of 2 groups: One group will stay on ART. They will have 2 study visits: the first 45 days after screening, and the second 12 to 16 weeks later. They will have a PET/CT scan at each

  • 0 views
  • 20 Sep, 2022
  • 1 location
Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer

scan. The PET/CT scan itself is about an hour. Participants may be asked to do a biopsy before treatment and 2 months after starting treatment. Participants will have a full

  • 50 views
  • 28 Jul, 2022
  • 1 location
Chemotherapy Followed by Irreversible Electroporation in Patients With Unresectable Locally Advanced Pancreatic Cancer (CHEMOFIRE-2)

This study is a single-arm clinical trial of irreversible electroporation (IRE) for the treatment of unresectable locally advanced pancreatic cancer (LAPC). The aim of the study is to evaluate the efficacy of IRE in this patient group. A statistical analysis of patient survival will be performed, comparing study participants to …

carcinoma
cancer
adenocarcinoma
solid tumors
  • 4 views
  • 16 Feb, 2022
  • 1 location
A Phase II Study of Efficacy and Safety of Induction Modified TPF (mTPF) Followed by Concurrent Chemoradiotherapy (CCRT) in Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LASCCHN)

The purpose of the study is to evaluate the efficacy and safety of induction mTPF chemotherapy followed by concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck cancer

  • 0 views
  • 19 Sep, 2022
  • 1 location